Related Experiment Videos
Breast tumors: evaluation with P-31 MR spectroscopy
Radiology
|October 1, 1986
Summary
Phosphorus-31 magnetic resonance (MR) spectroscopy revealed higher energy phosphate concentrations in breast carcinomas compared to benign tumors. This finding suggests P-31 MR spectroscopy could be a reliable diagnostic tool for breast cancer.
Area of Science:
- Biomedical Engineering
- Oncology
- Biochemistry
Background:
- Distinguishing between benign and malignant breast tumors is crucial for effective patient management.
- Understanding the metabolic differences between cancerous and non-cancerous breast tissue can aid in diagnosis.
Purpose of the Study:
- To investigate the energetic differences between breast carcinomas and benign breast tumors using phosphorus-31 magnetic resonance (MR) spectroscopy.
- To assess the potential of P-31 MR spectroscopy for diagnosing breast tumors.
Main Methods:
- Biopsy samples from nine breast carcinomas and five benign breast tumors were analyzed.
- Phosphorus-31 MR spectroscopy was employed to measure high-energy phosphate concentrations.
Main Results:
- Nucleoside triphosphates and phosphomonoesters were found to be approximately three times higher in carcinomas than in benign tumors.
- Carcinomas exhibited larger chemical shift differences in adenosine triphosphate (ATP) signals, indicating lower magnesium-bound ATP fractions.
- A decrease in free magnesium ions was observed in carcinomas compared to benign tumors.
Conclusions:
- P-31 MR spectroscopy can detect significant metabolic differences between breast carcinomas and benign tumors.
- In vivo P-31 MR spectroscopy shows promise as a non-invasive method for breast tumor diagnosis.